REQUEST A DEMO
Total
USD $0.00
Search more companies

Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Eusol Biotech Co., Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司) is an enterprise based in Taiwan, China. Its main office is in Taipei City. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on March 16, 2005. There are currently 9 (2023) people employed by Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司). Over the same period, its total assets decreased by 10.19%.

Headquarters
6F.,No.135, Sec.3, Minsheng E. Rd., Songshan Dist
Taipei City; Taipei City;

Contact Details: Purchase the Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司) report to view the information.

Website: http://www.eusol.com.tw

Basic Information
Total Employees:
Purchase the Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司) report to view the information.
Incorporation Date:
March 16, 2005
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
23.72%
Purchase this report to view the information.
21.81%
Purchase this report to view the information.
4.3%
Purchase this report to view the information.
2.34%
Purchase this report to view the information.
1.92%
Subsidiaries
Sequential Medicine Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Eusol Biotech Co., Ltd. (雅祥生技医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Total Operating Revenue
178.91%
Operating Profit
-11.59%
EBITDA
-17.65%
Net Profit/Loss for the Period
-45.99%
Total Assets
-10.19%
Total Equity
-9.81%
Return on Equity (ROE)
-2.53%
Debt / Equity
-810%
Quick Ratio
5417.36%
Cash Ratio
2.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?